DOI QR코드

DOI QR Code

Comparative Assessment of the Diagnostic Value of Transbronchial Lung Biopsy and Bronchoalveolar Lavage Fluid Cytology in Lung Cancer

  • Binesh, Fariba (Department of Pathology, Shahid Sadoughi University of Medical Sciences) ;
  • Pirdehghan, Azar (Department of Community Medicine, Shahid Sadoughi University of Medical Sciences) ;
  • Mirjalili, Mohammad Reza (Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences) ;
  • Samet, Mohammad (Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences) ;
  • Majomerd, Zahra Amini (Department of Pathology, Shahid Sadoughi University of Medical Sciences) ;
  • Akhavan, Ali (Department of Radiotherapy, Isfahan University of Medical Sciences)
  • Published : 2015.02.04

Abstract

Background: This study was designed to determine the accuracy of bronchoalveolar lavage fluid cytology (BAL) using histopathologic examination of transbronchial biopsy specimens as the gold standard in diagnosis of lung carcinoma at our center. Materials and Methods: A retrospective study was conducted to investigate a total of 388 patients who were suspected of having lung cancer and had undergone fiberoptic bronchoscopy in Shahid Sadoughi hospital from 2006 to 2011. Lung masses were proven to be malignant by histology. Results: Transbronchial lung biopsy (TBLB) identified malignancy in 183 of the 388 cases, including 48 cases (26.2%) with adenocarcinoma, 4(2.1%) with bronchioloalveolar carcinoma, 47(25.6%)with squamous cell carcinoma, 34(18.5%) with well-diffentiated neuroendocrine carcinoma, 35(19.1%) with small cell carcinoma, 14 (7.6%) with non-small cell carcinoma, and 1 (0.54%) with large cell carcinoma. A total of 205 cases were correctly classified as negative. BAL was also performed in 388 patients; 86/103 cases were consistent with the final diagnosis of lung cancer and 188/285 cases were correctly classified as negative. The sensitivity of BAL was 46.9%(CI:41.9%, 51.8%)) and its specificity was 91.6%(CI:88.8%, 94.3%). BAL had a positive predictive value (PPV) of 83.4%(CI:79.7%, 87.1%) and a negative predictive value (NPV) of 65.8%(CI:61%, 70.5%). The overall accuracy of BAL was 70.5% and the exact concordance was 39%. Conclusions: Our findings suggest that BAL cytology is not sensitive but is a specific test for diagnosis of lung carcinoma. If transbronchial lung biopsy is combined with bronchoalveolar lavage, the positive diagnostic rate will be further elevated.

Keywords

References

  1. Ahmed A, Ahmed S (2004). Comparison of bronchoalveolar lavage cytology and transbronchial biopsy in the diagnosis of carcinoma of lung. J Ayub Med Coll Abbottabad, 16, 29-33.
  2. Ahmed K, Abdullah-Al-Emran, Jesmin T, et al (2013). Early detection of lung cancer risk using data mining. Asian Pac J Cancer Prev, 14, 595-8. https://doi.org/10.7314/APJCP.2013.14.1.595
  3. Cho KH, Park SH, Lee KS, et al (2013). A single measure of cancer burden in Korea from 1999 to 2010. Asian Pac J Cancer Prev, 14, 5249-55. https://doi.org/10.7314/APJCP.2013.14.9.5249
  4. Dionisio J (2012). Diagnostic flexible bronchoscopy and accessory techniques. RevPort Pneumol, 18, 99-106.
  5. Kido T, Yatera K, Noguchi S, et al (2012). Detection of MALT1 gene rearrangements in BAL fluid cells for the diagnosis of pulmonary mucosa-associated lymphoid tissue lymphoma chest, 141, 176-82. https://doi.org/10.1378/chest.11-0068
  6. Lachman MF, Schofield K, Cellura K (1995). Bronchoscopic diagnosis of malignancy in the lower airway. A cytologic review. Acta Cytol, 39, 1148-51.
  7. Lam B, Wong MP, Ooi C, et al (2000). Diagnostic yield of bronchoscopic sampling methods in bronchial carcinoma. Respirology, 5, 265-70. https://doi.org/10.1046/j.1440-1843.2000.00258.x
  8. Li J, Chen P, Li X-Q, et al (2013). Elevated levels of survivin and livin mRNA in bronchial aspirates as markers to support the diagnosis of lung cancer, Int J Cancer, 5, 1098-104.
  9. Linder J, Radio SJ, Robbins RA, Ghafouri M, Rennard SI (1989). Bronchoalveolar lavage in the cytologic diagnosis of carcinoma of the lung. Arch Pathol Lab Med, 113, 333-6.
  10. Luqman M, Javed MM, Daud S, et al (2014). Risk factors for lung cancer in the Pakistani population. Asian Pac J Cancer Prev, 15, 3035-9. https://doi.org/10.7314/APJCP.2014.15.7.3035
  11. Margaritopoulos GA, Wells AU (2012). The role of transbronchial biopsy in the diagnosis of diffuse parenchymal lung diseases: Con. Rev Port Pneumol, 18, 61-3. https://doi.org/10.1016/j.rppneu.2011.09.004
  12. Myron R Melamed, Leopard G Koss (2009). Tumors of lung. in: Myron R Melamed, Leopard G Koss, editor. Koss' Diagnostic Cytology and its Histopathological Bases, 5th ed. Philadelphia: Lippincott Williams & Wilkins; p. 645-706.
  13. Piaton E, Grillet-Ravigneaux MH, Saugier B, Pellet H (1995). Prospective study of combined use of bronchial aspirates and biopsy specimens in diagnosis and typing of centrally located lung tumours. BMJ, 310, 624-7. https://doi.org/10.1136/bmj.310.6980.624
  14. Pirozynski M (1992). Bronchoalveolar lavage in the diagnosis of peripheral, primary lung cancer. Chest, 102, 372-4 https://doi.org/10.1378/chest.102.2.372
  15. Pradeep Kumar L, Rudramurthy K, Srinivasa Murthy G, Avanthi E (2014). Comparison of effectiveness of BAL [bronchoalveolar lavage] with CT Guided FNAC in the diagnosis of lung cancer. J Evolu Med Dental Sci, 11, 2752-6.
  16. Rennard SI (1990). Bronchoalveolar lavage in the diagnosis of cancer. Lung, 168, 1035-40. https://doi.org/10.1007/BF02718241
  17. Russell WO, Nedihardt HW, Mountain CF, Griffith KM, Chang JP (2003). The role of transbronchial lung biopsy in the diagnosis of solitary pulmonary nodule. Coll Antropol, 27, 669-75.
  18. Saenghirunvattana S, Charoenpan P, Kiatboonsri S, et al (1991). Final diagnosis of “suspicious for malignancy” from bronchial washing cytology. J Med Assoc Thai, 74, 196-9.
  19. Schwarz MI (2003). Miscellaneous interstitial lung diseases. in: Schwarz MI, King TE Jr, eds. Interstitial Lung Disease. Hamilton, ON: BC Decker: 877-916.
  20. Tang CC, Hsiao CJ, Chen H, et al (2000). Value of bronchoalveolar lavage combined with transbronchial lung biopsy in the diagnosis of peripheral lung cancer. Chang Gung Med J, 23, 695-700.
  21. Wang Li, Hong-Ying Liu, Zi-Ru Jia, et al (2014). Advances in the early detection of lung cancer using analysis of volatile organic compounds: from imaging to sensors. Asian Pac J Cancer Prev, 15, 4377-84. https://doi.org/10.7314/APJCP.2014.15.11.4377
  22. Wang WJ, Tao Z, Gu W, Sun LH (2013). Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination. Asian Pac J Cancer Prev, 14, 4369-71. https://doi.org/10.7314/APJCP.2013.14.7.4369
  23. Wongsurakiat P, Wongbunnate S, Dejsomritrutai W, et al (1998). Diagnostic value of bronchoalveolar lavage and postbronchoscopic sputum cytology in peripheral lung cancer. Respirology, 3, 131-7. https://doi.org/10.1111/j.1440-1843.1998.tb00111.x
  24. Yamamoto S (1994). Diagnostic value of bronchoalveolar lavage (BAL)-the comparative study with open lung biopsy and BAL. Rinsho Byori, 42, 265-70.
  25. Yasuda H, Soejima K, Nakayama S, et al (2011). Bronchoscopic microsampling is a useful complementary diagnostic tool for detecting lung cancer. Lung Cancer, 72, 32-8. https://doi.org/10.1016/j.lungcan.2010.07.016

Cited by

  1. Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer vol.7, pp.2045-2322, 2017, https://doi.org/10.1038/srep42190
  2. The new guidelines of Papanicolaou Society of Cytopathology for respiratory specimens: Assessment of risk of malignancy and diagnostic yield in different cytological modalities vol.46, pp.9, 2018, https://doi.org/10.1002/dc.24036